BioCentury
ARTICLE | Company News

Genzyme, Moffitt Cancer Center deal

January 21, 2008 8:00 AM UTC

Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. Moffitt Cancer Center, Tampa, Fla. Business: Pharmacogenetics The center granted Genzyme exclusive, worldwide rights to develop and commercialize diagnos...